11/19/2024When BeiGene Takes Off 'Bei' and Why NewCo Now: Three Biotech Go Globa...

11/14/2024China on the Move: New Level of Opening up in Health Care Sector (NLR)

11/14/2024Passage to Asia: Early Access for Innovative Therapies (PharmExec)

11/13/2024How China's Anti-Espionage Law Could Impact Pharmaceutical Supply Chai...

11/12/2024Life Sciences M&A Trends for 2023 And 2024 (Thru Q3) in Greater China ...

11/12/2024Precision Oncology Drug Development in China: Opportunities, Challenge...

11/12/2024Trump Presidency to Test Public Trust in Big Pharma (SWI)

11/11/2024China Biotech and the Bear: A Perspective (BioCentury)

11/11/2024Trump's Trade Tango Returns: Will China's Biotech Dance Through Anothe...

11/11/2024China Biopharma Tracker – October 2024 (PharmaDJ)

11/7/2024Stimulus Package vs. Drug Price Negotiation, Impacts on China's Health...

11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...

11/4/2024Big Pharma Doubles Down on China (The Wire China)

11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...

11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...

10/31/2024China Investigation of Drug Firm Exec Deals Latest Blow to Foreign Bus...

10/31/2024AstraZeneca's China Legal Woes Follow Push For Market Share (Bloomberg...

10/30/2024China's Compliance Guidelines for Healthcare Companies Signal Areas of...

10/29/2024VCs Move to Launch U.S.-Based Companies to Advance Drugs Developed in ...

10/24/2024Patent Term Extensions In China: Overviews And Takeaways (Mondaq)

10/24/2024Reinventing Your China Strategy: A Podcast Preview of the China Health...

10/24/2024U.S. and China Compete for Top Position in the Global Drug Development...

10/21/2024Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...

10/21/2024Clinical Benefit, Price, and Regulatory Approval of Cancer Drugs Grant...

10/16/2024As U.S. Efforts Stall, China Pushes Ahead with CRISPR Treatments for M...

10/16/2024Understanding the NewCo Model: A Trending Approach of Chinese Pharmace...

10/16/2024China Biopharma Tracker – Q3 2024 (PharmaDJ)

10/16/2024China's New Policies On Foreign Investment In Healthcare And Biotechno...

10/8/2024NRDL China: 2024 Outlook (Simon Kucher)

10/1/2024China's Pharmaceutical Antimonopoly Guidelines Pose New Challenges for...

Page:4/7 Total number of articles:195: [First][<<] [2] [3] [4] [5] [6] [>>] [End]